Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 12, 2018 01:00 ET | Source: Kuros Biosciences

Kuros Biosciences Announces Start of Randomized Controlled Trial of MagnetOs in Spinal Fusion

Study Should Further Enhance Competitive Positioning of MagnetOs SCHLIEREN (ZURICH), Switzerland, June 12, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) announced today that the University...
May 31, 2018 11:30 ET | Source: Kuros Biosciences

Kuros Biosciences to Propose Appointment of New Board Members at AGM

SCHLIEREN (ZURICH), Switzerland, May 31, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) will propose the appointment of CEO Joost de Bruijn, as well as three new independent non-executive...
May 29, 2018 11:30 ET | Source: Kuros Biosciences

Kuros Biosciences Announces Start of Investigator-Led Study of MagnetOs Granules for Maxillary Sinus Floor Elevation

SCHLIEREN (ZURICH), Switzerland, May 29, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) announced today the start of an investigator-led study at University Medical Center (UMC) Utrecht,...
May 02, 2018 01:00 ET | Source: Kuros Biosciences

Kuros Biosciences Receives European Clearance for MagnetOs Putty and Prepares for Commercial Roll-Out in the U.S. and Europe

SCHLIEREN (ZURICH), Switzerland, May 02, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) announced today that it has received the CE Mark for MagnetOs Putty indicated for use as an...
April 30, 2018 01:00 ET | Source: Kuros Biosciences

Kuros Biosciences Reports Full-Year 2017 Results

Financial highlights CHF 17.0 million cash at year-endCHF 16.9 million equity raise in June 2017Standby equity facility established in November 2017 to increase financial flexibility Operational...